Business profile & competitive position
Synopsys, Inc. (SNPS) sits in the Technology sector, specifically the Software - Infrastructure industry. Its core business is electronic design automation (EDA) software, silicon intellectual property (IP), simulation and analysis (S&A) software—including Ansys—and related design services. The company’s tools help chip and systems engineers design, verify, simulate, and test advanced integrated circuits and the electronic systems around them, with artificial intelligence increasingly embedded across the EDA flow to boost productivity. Customers span semiconductors, aerospace and defense, automotive, energy, healthcare, and broader electronics markets, served through a direct sales force plus a global network of channel partners.
The competitive profile implied by the numbers is nuanced. The trailing net margin of 11.4% is positive but modest for a company often described as a software leader, while the return on equity of 3.6% is notably low for a high-profile technology name. That spread between margin and ROE suggests the business is not a simple capital-light, high-return operator at this point. A more likely interpretation is that the balance sheet is carrying a heavier equity base from the Ansys merger and from acquired intangible assets, which compress ROE even while the underlying EDA and IP franchises continue to generate recurring revenue. The economic moat therefore likely rests on customer switching costs, entrenched EDA workflows, and a broad IP catalog rather than on fat current capital returns.
Financial posture
Synopsys currently commands a market capitalization of roughly $87.9 billion and trades at a trailing P/E of 79.6, supported by a net margin of 11.4% and an ROE of just 3.6%. The price-to-earnings ratio is steep relative to both the margin and the ROE, which tells us the market is pricing in substantial future growth and completion of the Ansys integration rather than current returns on equity. The stock’s beta is 1.18, meaning it has tended to move more than the broad market, consistent with a growth-oriented, M&A-integrated technology franchise.
At the current snapshot price of $458.73, the stock is trading above its 50-day exponential moving average of $449.34, and the RSI sits at 50.3, a neutral reading. Those technical snapshots do not resolve the valuation debate on their own, but they do show the name near a fairly balanced short-term momentum level heading into the next earnings event.
Strategic priorities & outlook
The company’s most recent 10-K filing frames the near-term agenda around closing the loop on its large Ansys transaction. The stated priorities include integrating Ansys, realizing the expected impact of the Ansys Merger, and developing joint solutions that combine the two companies’ products and capabilities. Synopsys also plans to reallocate resources within its Design IP segment toward higher-growth opportunities, pursue customer license renewals, and manage the recognition and timing of backlog. Additional operational goals include completing development of unfinished products and further integrating existing products.
On the structural side, Synopsys divested its Optical Solutions Group to Keysight Technologies in October 2025, changed its fiscal year-end to October 31 beginning in fiscal 2025, and reported approximately 28,000 employees at fiscal 2025 year-end, with about 77% located outside the United States. The high non-U.S. headcount is relevant for cost structure, currency exposure, and tax footprint as the company digests the Ansys combination.
Macro & geopolitical exposure
As a Software - Infrastructure provider tied to the semiconductor ecosystem, Synopsys is exposed to the global chip-capital spending cycle. When foundries, systems houses, and automotive OEMs cut capex or push out tape-outs, EDA license growth can slow even if recurring revenue provides a cushion. The semiconductor industry is also squarely in the crosshairs of U.S.-China trade and export-control policy, including restrictions on advanced chips and the design tools used to produce them. Because EDA software is foundational to leading-edge chip development, it is a plausible target of licensing, export, or end-user restrictions.
With roughly three-quarters of its workforce based outside the United States, Synopsys carries meaningful foreign-exchange and labor-market exposure. Currency translation can affect both reported revenue and overseas payroll costs, while geopolitical friction can influence hiring, data-transfer rules, and intellectual-property protections in key development regions. On the M&A front, large consolidation—such as the Ansys deal—can attract antitrust and foreign-investment scrutiny in multiple jurisdictions. Cybersecurity and IP theft are further industry-level risks because the underlying software source code and design IP are high-value targets.
Recent developments
Recent headlines around SNPS have mixed signals. On November 9, 2026, defenseworld.net reported that Ethic Inc. lowered its stock position in Synopsys. On November 6, 2026, zacks.com published a piece titled “3 Reasons Growth Investors Will Love Synopsys (SNPS),” highlighting growth-oriented angles in the name. That followed a November 5, 2026 zacks.com article noting that Synopsys had dipped more than the broader market, signaling weak near-term price action. Also on November 5, 2026, Synopsys issued a press release via prnewswire.com announcing the earnings release date for its fourth quarter and fiscal year 2026.
Those items line up with the current technical profile: modest, near-neutral momentum after a stretch of relative underperformance, with investors now looking toward the upcoming quarterly report scheduled for December 8, 2026, after the close.
Earnings behavior & post-earnings drift
Synopsys has an impressive recent earnings record. Over the last eight reported quarters, the company beat estimates 7 out of 8 times, for an 88% beat rate, with an average earnings surprise of 4%. Despite that track record, the average five-day price move following those reports has been -3.17%, classified as a downward post-earnings drift. That divergence is important: beating the published estimate has not, on average, been enough to lift the stock over the following week.
The most recent four quarters illustrate the pattern clearly. On August 26, 2026, Synopsys reported actual EPS of $3.91 against an estimate of $3.67, a 6.5% surprise, and the stock jumped 13.39% the next day and rose 1.46% over the following five days. The prior three quarters, however, all beat as well and still saw pressure. On May 27, 2026, EPS of $3.35 beat $3.15 by 6.3%, yet the stock fell 8.61% the next day and 5.30% over five days. On February 25, 2026, EPS of $3.77 beat $3.56 by 5.9%, producing a next-day drop of 5.16% and a five-day decline of 4.05%. And on December 10, 2025, EPS of $2.90 beat a $2.78 estimate by 4.3%, with the stock up only 0.3% the next day before sliding 4.78% over the next five days.
One interpretation is that the market’s real expectation for Synopsys has consistently run above the published consensus, so even clean beats can be met with selling as investors recalibrate to guidance, M&A integration progress, or backlog timing. The next scheduled report on December 8, 2026, after the close, carries a current consensus EPS estimate of $4.12.
Frequently Asked Questions
What does Synopsys actually sell?
Synopsys provides electronic design automation (EDA) software, silicon intellectual property (IP), simulation and analysis software, and design services. Its tools help engineers design, verify, simulate, and test advanced chips and the systems that use them, with AI being woven into the EDA workflow to improve productivity.
Why is Synopsys’s ROE only 3.6% if its net margin is positive?
The low ROE relative to the 11.4% net margin suggests a high equity base, likely influenced by the Ansys acquisition, goodwill, and intangible assets. The company is generating earnings, but the denominator in the ROE calculation is large, which compresses the current return on equity figure.
How has Synopsys stock typically reacted after earnings?
Over the last eight quarters, Synopsys has beaten estimates 88% of the time with an average surprise of 4%. However, the average five-day drift after those reports has been -3.17% to the downside, showing that beats are not always rewarded with immediate price strength.
For a deeper dive into how institutional analysts are interpreting Synopsys ahead of the December 8, 2026 report, explore our full institutional verdict on the name.
| Reported | Actual | Estimate | Surprise | 1D Move | 5D Move |
|---|---|---|---|---|---|
| 2026-08-26 | $3.91 | $3.67 | +6.5% | +13.39% | +1.46% |
| 2026-05-27 | $3.35 | $3.15 | +6.3% | -8.61% | -5.3% |
| 2026-02-25 | $3.77 | $3.56 | +5.9% | -5.16% | -4.05% |
| 2025-12-10 | $2.9 | $2.78 | +4.3% | +0.3% | -4.78% |
| 2025-09-09 | $3.39 | $3.8 | -10.8% | - | - |
| 2025-05-28 | $3.67 | $3.39 | +8.3% | - | - |
Previous SNPS editions
Get the institutional verdict on SNPS
Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.
Read the SNPS verdict at Gamma QCVerify authenticity
Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.